HomeSearchDrug Development Research

Drug Development Research

John Wiley & Sons Inc. · United States

ISSN0272-4391eISSN1098-2299
SJR Q2WOS SCIEScopus / SJR
43
/ 100
Medium Risk
Score Breakdown
WoS SCIE/SSCI+25
Scopus Q2+18
Total43
Journal Impact Factor
This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗
SJR Score
0.756
H-Index
96
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIP
0.805
Total Works
5,094
Total Citations
72,484
2yr Mean Citedness
2.84
Free JIF alternative
Retractions
5
Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on the development of novel therapeutic agents and strategies for various diseases. Research includes the design, synthesis, and evaluation of small molecules, nanocarriers, and other drug modalities targeting cancer, neurodegenerative diseases, inflammatory disorders, and infectious diseases. Emphasis is placed on understanding mechanisms of action, overcoming drug resistance, and improving drug delivery for enhanced efficacy and reduced toxicity.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Q2
SJR Rank
Top 50% in field

General Information

Country / RegionUnited States
Primary LanguageEnglish
1st Year Published
Annual Volume~ 163 articles / year
StatusActive
Total Publications5,094
Publisher OrgWiley
Visit Journal Website

Submission Info

Publishing ModelHybrid
Peer Review
Review Time
Acceptance Rate
OA License
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Hybrid journal — subscription model available.

Think.Check.Submit Compliance

6/12 · 50%
Do you know the journal / publisher?
John Wiley & Sons Inc.
Does the journal have a website?
✓ Linked
Is the ISSN verified?
0272-4391 / 1098-2299
Indexed in a trusted database?
WoS, Scopus
Peer review process documented?
N/A
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
N/A
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
N/A
Listed in DOAJ (verified OA)?
N/A
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug DiscoveryQ2

Subject Classification

Web of Science Categories

Chemistry, MedicinalPharmacology & Pharmacy

Scopus Categories

Drug Discovery

Research Topics (OpenAlex)

Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorAdenosine and Purinergic SignalingCholinesterase and Neurodegenerative Diseases
Compare This JournalFind Similar← Back to Search

Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref